These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 20345754)
1. Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions. Jang A; Lee HJ; Suk JE; Jung JW; Kim KP; Lee SJ J Neurochem; 2010 Jun; 113(5):1263-74. PubMed ID: 20345754 [TBL] [Abstract][Full Text] [Related]
2. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Smith WW; Jiang H; Pei Z; Tanaka Y; Morita H; Sawa A; Dawson VL; Dawson TM; Ross CA Hum Mol Genet; 2005 Dec; 14(24):3801-11. PubMed ID: 16239241 [TBL] [Abstract][Full Text] [Related]
3. Controlling the mass action of alpha-synuclein in Parkinson's disease. Kim C; Lee SJ J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382 [TBL] [Abstract][Full Text] [Related]
5. Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins. Schnack C; Danzer KM; Hengerer B; Gillardon F Neuroscience; 2008 Jul; 154(4):1450-7. PubMed ID: 18541383 [TBL] [Abstract][Full Text] [Related]
6. Identification of rotenone-induced modifications in alpha-synuclein using affinity pull-down and tandem mass spectrometry. Mirzaei H; Schieler JL; Rochet JC; Regnier F Anal Chem; 2006 Apr; 78(7):2422-31. PubMed ID: 16579629 [TBL] [Abstract][Full Text] [Related]
7. Oxidative stress induces nuclear translocation of C-terminus of alpha-synuclein in dopaminergic cells. Xu S; Zhou M; Yu S; Cai Y; Zhang A; Uéda K; Chan P Biochem Biophys Res Commun; 2006 Mar; 342(1):330-5. PubMed ID: 16480958 [TBL] [Abstract][Full Text] [Related]
8. Calpain-resistant fragment(s) of alpha-synuclein regulates the synuclein-cleaving activity of 20S proteasome. Kim HJ; Lee D; Lee CH; Chung KC; Kim J; Paik SR Arch Biochem Biophys; 2006 Nov; 455(1):40-7. PubMed ID: 17005155 [TBL] [Abstract][Full Text] [Related]
9. Impairment of microtubule-dependent trafficking by overexpression of alpha-synuclein. Lee HJ; Khoshaghideh F; Lee S; Lee SJ Eur J Neurosci; 2006 Dec; 24(11):3153-62. PubMed ID: 17156376 [TBL] [Abstract][Full Text] [Related]
10. Human α-synuclein modulates vesicle trafficking through its interaction with prenylated Rab acceptor protein 1. Lee HJ; Kang SJ; Lee K; Im H Biochem Biophys Res Commun; 2011 Sep; 412(4):526-31. PubMed ID: 21798244 [TBL] [Abstract][Full Text] [Related]
11. G protein-coupled receptor kinase 5, overexpressed in the alpha-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression. Liu P; Wang X; Gao N; Zhu H; Dai X; Xu Y; Ma C; Huang L; Liu Y; Qin C Brain Res; 2010 Jan; 1307():134-41. PubMed ID: 19852948 [TBL] [Abstract][Full Text] [Related]
12. alpha-Synuclein enhances secretion and toxicity of amyloid beta peptides in PC12 cells. Kazmierczak A; Strosznajder JB; Adamczyk A Neurochem Int; 2008 Dec; 53(6-8):263-9. PubMed ID: 18804502 [TBL] [Abstract][Full Text] [Related]
13. Activity-dependent secretion of alpha-synuclein by enteric neurons. Paillusson S; Clairembault T; Biraud M; Neunlist M; Derkinderen P J Neurochem; 2013 May; 125(4):512-7. PubMed ID: 23278133 [TBL] [Abstract][Full Text] [Related]
14. Rifampicin protects PC12 cells against MPP+-induced apoptosis and inhibits the expression of an alpha-Synuclein multimer. Xu J; Wei C; Xu C; Bennett MC; Zhang G; Li F; Tao E Brain Res; 2007 Mar; 1139():220-5. PubMed ID: 17280646 [TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates. Purisai MG; McCormack AL; Langston WJ; Johnston LC; Di Monte DA Neurobiol Dis; 2005 Dec; 20(3):898-906. PubMed ID: 16006134 [TBL] [Abstract][Full Text] [Related]
16. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336 [TBL] [Abstract][Full Text] [Related]
17. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734 [TBL] [Abstract][Full Text] [Related]
18. Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Lee HJ; Suk JE; Bae EJ; Lee JH; Paik SR; Lee SJ Int J Biochem Cell Biol; 2008; 40(9):1835-49. PubMed ID: 18291704 [TBL] [Abstract][Full Text] [Related]
19. Protein synthesis inhibitors and the chemical chaperone TMAO reverse endoplasmic reticulum perturbation induced by overexpression of the iodide transporter pendrin. Shepshelovich J; Goldstein-Magal L; Globerson A; Yen PM; Rotman-Pikielny P; Hirschberg K J Cell Sci; 2005 Apr; 118(Pt 8):1577-86. PubMed ID: 15784681 [TBL] [Abstract][Full Text] [Related]
20. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease? Chu Y; Kordower JH Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]